Mobia Medical, Inc. (NASDAQ:MOBI) Stock Has Consensus Target Price of $20.75

Mobia Medical, Inc. (NASDAQ:MOBI) has been given a consensus recommendation of “Moderate Buy” by the seven analysts that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $20.75.

A number of analysts have issued reports on MOBI shares. Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Weiss Ratings started coverage on shares of Mobia Medical in a research report on Wednesday, August 12th. They set a “sell (e-)” rating on the stock. BTIG Research reissued a “buy” rating and issued a $19.00 price objective on shares of Mobia Medical in a report on Wednesday, August 12th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th.

Insider Buying and Selling at Mobia Medical

In other news, Director Casey Tansey purchased 16,441 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was acquired at an average price of $12.07 per share, with a total value of $198,442.87. Following the purchase, the director directly owned 318,332 shares in the company, valued at approximately $3,842,267.24. This represents a 5.45% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Over the last three months, insiders have purchased 87,000 shares of company stock valued at $1,016,367.

Institutional Trading of Mobia Medical

Several institutional investors have recently made changes to their positions in MOBI. Citadel Advisors LLC purchased a new position in Mobia Medical in the second quarter worth approximately $670,000. State Street Corp acquired a new stake in Mobia Medical during the second quarter worth $735,000. Finally, Readystate Asset Management LP purchased a new stake in Mobia Medical in the second quarter valued at $134,000.

Mobia Medical Price Performance

Shares of Mobia Medical stock opened at $8.51 on Monday. The firm has a market cap of $283.30 million and a PE ratio of -0.42. The business’s 50 day moving average is $10.75. Mobia Medical has a 1-year low of $8.45 and a 1-year high of $15.29. The company has a current ratio of 13.28, a quick ratio of 12.80 and a debt-to-equity ratio of 0.04.

Mobia Medical (NASDAQ:MOBI) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) EPS for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The company had revenue of $13.51 million during the quarter. Mobia Medical’s revenue for the quarter was up 102.4% compared to the same quarter last year. As a group, research analysts expect that Mobia Medical will post -2.63 EPS for the current fiscal year.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.